Researchers analyzed 4,130 treatment-naive patients with chronic HBV infection who visited either a primary care physician (616 patients), community gastroenterologist (2,251 patients) or university hepatologist (1,263 patients) between 2002 and 2016.
Here’s what they found:
1. Guideline adherence was highest among patients who visited a hepatologist.
2. About 80 percent of patients visiting a hepatologist adhered to guidelines.
3. In comparison, 59.8 percent visiting gastroenterologists and 36.69 percent visiting primary care physicians adhered to guidelines.
Researchers concluded, “Such findings suggest that there remains a lack of knowledge on the availability and effectiveness of [chronic HBV] treatment, likely both at provider and patient levels. Therefore, efforts should be directed toward educating all practitioners and patients on the availability of treatment guidelines, which includes appropriate [chronic HBV] evaluation and effective antiviral therapies, which is especially important for [chronic HBV] highly prevalent communities.”
More articles on gastroenterology:
FDA approves opioid 10x stronger than fentanyl as crisis continues — 5 insights
Twin Cities Pain Clinic radiologic technologist discusses job perks, misconceptions & more — 3 quotes
Quarterly reports on Tenet, Surgery Partners & more — 8 ASC company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
